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This review focuses on recent ﬁndings in pathobiology of osteoarthritis (OA). The progress in this ﬁeld
will be illustrated based on three questions; 1. What factors maintain or alter the articular chondrocyte
phenotype? 2. What is the role of inﬂammation in OA? 3. Is there a role for aging-related genes in OA?
Recent ﬁndings make it more and more obvious that OA is not a single tissue disease, but that devel-
opment and progression of OA is the resulted of an integrated complex of local and systemic factors that
contribute to the pathobiology of this widespread disease.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a common and until now untreatable
disease, except by total joint replacement, that leads to loss of joint
function. The main characteristic of OA is loss of articular cartilage,
but also other joint tissues appear to play an important role in the
disease process. The biology of OA is very broad and covers several
different tissues and a vast number of molecular players. In this
review, addressing ﬁndings reported in 7 months before the OARSI
meeting in Barcelona, it is impossible to deal with all potential
processes and an in depth review of all biological actors is therefore
unattainable. The focus of this paper will be on a small number of
central questions in the biology of OA that are currently attention-
grabbing, but remain a personal selection. Elucidation of these
questions is important for our view on the biology of OA and the
development of adequate treatments of this widespread disease.
This review will focus on the following questions; 1. What factors
maintain or alter the articular chondrocyte phenotype? 2. What is the
role of inﬂammation in OA? 3. Is there a role for aging-related genes in
OA? A selection of ﬁndings concerning these questions will be
discussed.P.M. van der Kraan, Depart-
Centre, Geert Grooteplein 28,
; Fax: 31-24-3540403.
s Research Society International. PWhat factors maintain or alter the articular chondrocyte
phenotype?
OA is characterized by degradation of articular cartilage. The
chondrocytes itself contribute to the degradation of articular
chondrocytes, by enzymatic degradation of the extracellular matrix
(chondrocytic chondrolysis). These cells, that in healthy cartilage
maintain the homeostasis of this tissue, are not able to preserve
articular cartilage in OA. Since chondrocytes play a crucial role in
articular cartilage homeostasis, the regulation of chondrocyte
behavior is a central theme in OA research.
Healthy articular cartilage is a stable tissue that functions for
decades to keep normal joint movement possible. In contrast,
growth plate and osteophytic cartilage are temporary and subject
to endochondral ossiﬁcation. Features of this process are thought to
occur in OA cartilage at least in a part of the patients. Gelse et al.
compared gene expression in intact human articular cartilage with
gene expression in the cartilaginous layer of osteophytes1. As ex-
pected, osteophytic chondrocytes showed expression of genes
involved in endochondral ossiﬁcation, such as BMP-8B, sclerostin
and Runx2. Also enzymes mediating tissue remodeling, like MMP9
and MMP13, were signiﬁcantly higher expressed in osteophytic
chondrocytes. In contrast, articular chondrocytes showed elevated
expression of inhibitors for the BMP- and wnt-signaling pathways.
The BMP inhibitor gremlin was the gene with the highest expres-
sion in articular chondrocytes compared to osteophytic chon-
drocytes. The high gremlin expression suggests that blocking BMPublished by Elsevier Ltd. All rights reserved.
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differentiation and that loss of this blockage and elevated BMP
signaling might release the brake on chondrocyte endochondral
ossiﬁcation and matrix breakdown.
Chondrocyte differentiation is regulated by protein encoding
genes, but more and more it becomes clear that additional mech-
anisms and actors are in play. Small non-coding RNAs (microRNAs,
miRs) are important regulators of gene expression and cellular
differentiation2. In an experiment with ATDC5 cells stimulated to
undergo chondrogenic differentiation, miR-455 and miR-140,
increased alongside the chondrogenic differentiation. Expression
of miRNA-455 was induced by TGF-b1, TGF-b3 and activin and
blocked Smad-dependent signaling3. Three direct targets of miR-
455 appeared to be Smad2, chordin-like 1 and activin receptor
2B. In an earlier study, the same authors showed that miR-140
targets Smad34. Both miR-140 and miR-455 showed increased
expression in OA cartilage compared to controls. The authors
suggest that terminal differentiation of chondrocytes is regulated
by miRNAs and that elevated expression of miR-140 and miR-455
decreases Smad2/3 signaling and that reduced Smad2/3 signaling
leads to OA development, as reported earlier5.
Not only BMP and TGF-b signaling appears to play a role in
regulation of chondrocyte behavior, also the wnt-signaling
pathway is considered to be, as also suggested in the study
mentioned above, vital in this process. Glycogen synthase kinase-
3b (GSK3b) blocks the canonical wnt pathway by promoting
degradation of b-catenin. When blocking GSK3b activity by intra-
articular injection of the potent and speciﬁc inhibitor GIN, b-cat-
enin accumulation was observed in the chondrocytes of rat knee
joints6,7. Three intra-articular injections with GIN in rat knee joints
led to OA-like features in the articular cartilage after 6 weeks. A
limitation of this study is the fact that GSK3b is not only involved in
canonical wnt signaling but also in other signaling routes, such as
the TGF-b signaling route via modulation of Smad degradation8.
Autophagy is an important cell survival mechanism that has
drawn great attention lately, also for its role chondrocyte in
homeostasis. Autophagy is an evolutionary conserved process that
leads to the degradation of “unnecessary” cellular components and
has been suggested to play a role in OA9. In a study of Sasaki et al., it
was shown that autophagy was up regulated in human OA chon-
drocytes compared to normal chondrocytes10. Moreover, they
showed that cellular stress increased expression of autophagy
markers in chondrocytes. Induction of autophagy, using rapamycin,
inhibited IL-1-induced gene expression changes while inhibition of
autophagy, blocking the autophage essential gene ATG5, exacer-
bated these effects. This shows that autophagy is a protective
mechanism for chondrocytes under stress.
The above described observations exemplify that regulation of
chondrocyte behavior is a complex process. Apparently, cartilage
homeostasis is controlled by a myriad of interacting factors. In
addition, aging, genetic make-up, local environmental factors, like
inﬂammation and joint loading, affect the chondrocyte. To develop
an adequate treatment for OA, the elucidation of a dominant
aberrant process that is abnormal in OA should be very helpful, but
until now a single biological pathway that leads to OA appears hard
to identify. Moreover, most likely different players and pathways
will be prevalent in different OA patient groups.
What keeps an articular chondrocyte functioning as an articular
chondrocytes is a central question in the structural cartilage
changes seen in OA. The chondrocytes have to be in good shape to
maintain functioning cartilage. However, since cartilage damage on
its own does not immediately lead to clinical symptoms and pain,
changes in other joint tissues, such as synovial inﬂammation, are
highly relevant for the treatment of OA symptoms. Moreover,
pathological alterations in other joint tissues than cartilage willhave their effects on articular cartilage. The synovial joint has to be
considered as an organ with communicating tissues that inﬂuence
each others behavior. What is more, increasingly it becomes clear
that also systemic factors inﬂuence OA development11.
What is the role of inﬂammation in OA?
Although a large part of OA patients show inﬂammation in their
affected joints, the pathological role of inﬂammation in OA devel-
opment and progression is not clariﬁed12. In a study in Nature
Medicine by Wang et al., it was reported that proteins of the
complement systemwere differently expressed in OA synovial ﬂuid
in comparison with healthy synovial ﬂuid13. Complement activa-
tionwas apparent both during early and late stages of OA and it was
found that the synovium contributed to the elevated complement
activation in OA. The authors furthermore investigated the role of
complement in an OA mouse model that was induced by medial
meniscectomy, comparing C5-deﬁcient and wild type mice. The
effector C5 is central in the complement cascade14. The C5-deﬁcient
micewere protected against OA and showed 16weeks after surgery
less cartilage damage, synovitis and osteophyte formation than
controls. In contrast, mice deﬁcient for CD59a, an inhibitor of the
complement cascade effector machinery (Membrane Attack
Complex, MAC), developed more severe OA and synovitis. More-
over, CD59b deﬁciency worsened the spontaneous OA both in old
mice and in mice with surgically (DMM)-induced OA. Extensive
deposition of MAC can lead to cell death while moderate MAC
deposition can activate pro-inﬂammatory signaling pathways. The
authors demonstrated that in human OA cartilageMAC co-localized
with MMP13. In C5-deﬁcient mice, that were also deﬁcient in MAC,
lower expression of inﬂammatory and degradative mediators was
observed. These data point toward a signiﬁcant role for comple-
ment activation in the pathogenesis of OA.
Inﬂammation can be a local process but it has its systemic
counterpart. Obesity is considered to be a form of systemic low-
grade inﬂammation and highly-associated with OA15. A mouse
strain that is both obese and shows spontaneous OA development
at a young age is the STR/ort strain. Kyostio-Moore et al. found that
this mouse strain showed both a local and systemic pro-
inﬂammatory state compared to the control CBA strain16. Serum
analysis showed elevated levels of several inﬂammatory cytokines,
such as IL-1b, and serum cytokine concentrations correlated with
joint pathology. Tissue markers of inﬂammation, AGE and HMBG1,
were strongly elevated in cartilage, meniscus, ligaments and
hyperplastic synovium. In this obese mouse strain both local and
systemic and inﬂammatory mediators go hand in hand with
increased susceptibility for OA and the authors consider this model
therefore a clinically relevant OA model.
In humans the metabolic syndrome is associated with OA17.
Recently Grifﬁn et al. showed that also in mice diet-induced obesity
was related to OA development and that OA development went
hand in hand with expression of behavioral, biomechanical, and
molecular risk factors17,18. In a follow-up study, these authors
showed that short-term wheel running protected against obesity-
induced OA in fat mice by modulating systemic inﬂammation19.
Obesity induced by a very high-fat diet caused OA and systemic
inﬂammationwas proportional to body fat. Short-term running did
not result in reduced body weight or body fat but partially elevated
glucose clearance. Remarkably, wheel running partly prevented the
fat-induced OA in the medial femur.
A high-fat diet led to signiﬁcant increased leptin and adipo-
nectin levels as expected, but also in an increase in KC and MIG and
a decrease in the anti-inﬂammatory cytokine IL-4. Exercise
increased IL-10 ﬁfteenfold in the high-fat diet mice. The concen-
tration of KC, leptin and IL-1Ra were positively associated with the
Fig. 1. Local and systemic interactions that are involved in OA pathophysiology and
symptoms.
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mation to knee OA was not obvious; inﬂammation was related to
increased adiposity and not to knee OA. However, exercise
improved glucose clearance and interrupted the co-expression of
pro-inﬂammatory cytokines. Moreover, since the running mice did
not loose weight but were partly protected against OA this study
indicates that increased joint loading is not the major factor in
obesity-induced OA in mice.
Another study examined the effect of a high-fat diet on OA
development in human CRP-transgenic mice20. Part of the animals
on a high-fat diet was treated with a statin (rosuvastatin) or
a PPARg inhibitor (rosiglitazone). The switch to a high-fat diet
resulted in increased expression of human CRP that was prevented
by both drugs. After 42 weeksmale mice showed signiﬁcantly more
severe OA thanmice on chow but therewas no association between
body weight and OA. Remarkably, both drug treatments resulted in
OA grades comparable to those in control animals. Apparently,
high-fat diet-induced OA can be modulated with drugs with anti-
inﬂammatory properties in mice.
Systemic inﬂammation appears to be associated with OA
development. This appears to be not only the case for OA but also
for other age-related diseases such as Alzheimer’s Disease (AD)21.
An association between OA and AD in a mouse model has been
recently suggested22. Local over expression of human IL-1b in
murine knee joints resulted in ﬁbrillation and erosions after 8
weeks. Surprisingly, 2 months after the induction of OA, in the brain
of these mice astrocyte and microglia activation was observed.
Moreover, a signiﬁcant up regulation of IL-1b and TNF-a was
demonstrated. Both cell activation and cytokine up regulation
returned to base line after 6 months. No evidence for IL-1b in the
serum of OA mice was found. In a mouse model of AD, APP/PS1
mice, IL-1b-induced OA-like pathology was associated with accel-
erated and enhanced AD pathology.
These and above data indicate that systemic inﬂammation is
a risk factor for both OA and AD, and that peripheral inﬂammation
is associated with AD. Circulating cytokines, triggered by the OA
process in the joint, might inﬂuence the central nervous system.
Since OA is a very prevalent disease in the elderly such a relation-
ship could have a large impact on the overall mental health. In this
respect it is interesting to point to the relationship between OA and
depression, and the association between depression and circulating
cytokines23,24. Fascinatingly, although it is obvious thatmouse OA is
not a precise copy of human OA, it appears that these complex
associations between inﬂammation, pathology and behavior can be
reproduced in a small animal model.
Is there a role for aging-related genes in OA?
Like depression and AD, development of OA is highly age-
related, and age is the risk factor most strongly correlated to
OA25. This strong association has triggered the research in the role
of aging in OA for several decades26,27. The protein deacetylase
SirT1 has an important role in life span determination and regulates
fat and glucose metabolism28. It has been reported that chon-
drocyte survival is increased by full-length SirT129. A decrease of
full-length SirT1 levels in aging mice was recently described by
Gabay et al.30. Comparing wild type mice with SirT1 heterozygous
mice showed no signiﬁcant differences in cartilage morphology at
an age of 1 month, but loss of aggrecan and increased OA severity
were seen in 9 month old heterozygous mice. Moreover, 9 month
old heterozygous mice showed a marked increase in chondrocyte
apoptosis compared to wild type mice. The authors suggest that
a cathepsin B cleavage product of SirT1, 75SirT1, that was only
found in 9 month old wild type mice protects chondrocytes against
apoptosis. The investigators conclude that loss of full-length SirT1inhibits the expression of type II collagen and aggrecan but that the
75SirT1 variant protects chondrocytes against apoptosis.
A disease showing accelerated aging is the HutchinsoneGilford
progeria syndrome. This syndrome is associated with a mutation
that leads to accumulation of a truncated, farnesylated lamin A
form. Patients with this mutation show bone and joint abnormal-
ities at a young age31. In OA cartilage, lamin A appears to be up
regulated both on mRNA and protein level32. In addition, over
expression of lamin A in chondrocytes resulted in a decreased cell
proliferation and viability. This was accompanied by increased
expression of cellular senescencemarkers, caspase-3 activation and
apoptosis. These ﬁndings indicate that alterations in lamin A
function are related to chondrocyte senescence and apoptosis.
However, although both aging-related molecules show a relation-
ship between alterations in these molecules and chondrocyte
apoptosis, the speciﬁc contribution of apoptosis to OA development
and progression is not settled yet.
Concluding remarks
This review focuses on a number of biological ﬁndings in the
ﬁeld of OA research reported in the last year. These ﬁndings illus-
trate that although articular cartilage is the tissue considered to be
mainly affected by OA, and that chondrocytes are the major players
in cartilage degradation, other joint tissue as well as systemic
metabolic processes determine the development and progression
of OA (Fig. 1). This in combinationwith the genetic background, the
structure of the extracellular matrix, effect of joint loading, joint
shape and the unpreventable aging process determine the initia-
tion and progression of OA. This view of OA, that has changed form
a single tissue disease to a “complex, multisystem disease”, has the
major advantage that it has provided several new levels that can be
targeted for the treatment of OA patients. That OA can be
successfully targeted, at least in animal models, was shown in
a study by Johnson et al.33. The small molecule kartogenin that was
identiﬁed in a high trough-put screen from 22.000 candidates
showed signiﬁcant OA protective effects in two OA animal models.
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